Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × HER2 Positive Breast Carcinoma × neratinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 21 Neoplasms 5 Neoplasm Metastasis 3 Advanced Malignant Solid Tumors 3 Lung Neoplasms 2 HER2+ Metastatic Breast Cancer (MBC) 1 HER2 Positive Breast Carcinoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

neratinib 1 Geriatric Assessment 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02673398 2023-06-18

Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer

City of Hope Medical Center

Phase 2 Completed

25 enrolled 18 charts

HER2 Positive Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡